The role of oesophageal stenting in the non-surgical management of oesophageal strictures.
The role of oesophageal stenting continues to evolve, with several new stents currently on the market. These stents possess anti-reflux valves, internal plastic coatings and retrievable threads. In patients with malignant dysphagia, management should ideally take place within multi-disciplinary teams such that accurate tumour staging occurs prior to treatment. Multi-modality therapy can not only improve dysphagia and response rates but may also improve survival. Several non-surgical palliative techniques are available to recanalize malignant obstruction, including oesophageal stenting. Other therapeutic modalities include the use of endoluminal laser therapy, photodynamic therapy, argon beam and bipolar electrocoagulation, ethanol injection and intracavity brachytherapy. Their use often depends on local availability and expertise. Although the initial costs of metal stents are high, the overall costs compare favourably with other forms of palliative therapy that often require multiple procedures with repeated inpatient hospitalization. Treatment of refractory benign strictures with oesophageal stents remains uncommon and several recent reports using retrievable stents appear to improve outcome, although more work is required in this area.
Lee
S H
SH
Department of Radiology, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK.
D002637:Chest Pain / Q000209:etiology; D019160:Endosonography; D004867:Equipment Design; D004937:Esophageal Fistula / Q000209:etiology; D004938:Esophageal Neoplasms / Q000150:complications / Q000000981:diagnostic imaging; D004939:Esophageal Perforation / Q000209:etiology; D004940:Esophageal Stenosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D004947:Esophagus / Q000000981:diagnostic imaging; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D009367:Neoplasm Staging; D018579:Patient Selection; D011015:Pneumonia, Aspiration / Q000209:etiology; D015607:Stents / Q000009:adverse effects; D014057:Tomography, X-Ray Computed